Intensive Treatment on Periodontitis in Aortic Stenosis

NCT ID: NCT06587971

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

920 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-10

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to determine if standardized periodontal therapy can effectively slow the progression of aortic valve stenosis in adult patients diagnosed with moderate aortic valve stenosis and coexisting gingivitis or mild-to-moderate periodontitis.

The main questions it aims to answer are: Can periodontal therapy slow the progression of aortic valve stenosis? Is chronic periodontitis an independent risk factor for the accelerated progression of aortic valve stenosis? Researchers will compare a group of patients receiving standardized periodontal therapy to a control group receiving only oral hygiene education to see if periodontal treatment results in a slower progression of aortic valve stenosis.

Participants will undergo initial screening to confirm eligibility based on aortic valve peak velocity and periodontal status. They will then be randomly assigned to either the treatment group, which will receive comprehensive periodontal therapy, or the control group, which will receive only oral hygiene education. Participants will be followed up regularly over a 36-month period, with assessments including echocardiograms to monitor the progression of aortic valve stenosis, periodontal examinations to assess oral health status, and blood tests to measure relevant serum biomarkers. The study will also track any cardiovascular events and adverse events related to the interventions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Stenosis Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comprehensive Periodontal Intervention Group

Administering the current guideline-recommended comprehensive periodontal treatment protocol to participants, which includes:

Oral hygiene education: Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.

Standard periodontal treatment protocol: Administering standard treatments for chronic periodontitis according to the current guidelines, including supragingival scaling, subgingival scaling, root planing, and periodontal flap surgery.

Group Type EXPERIMENTAL

Standard periodontal treatment protocol

Intervention Type PROCEDURE

Administering standard treatments for chronic periodontitis according to the current guidelines, including supragingival scaling, subgingival scaling, root planing, and periodontal flap surgery.

Oral hygiene education

Intervention Type BEHAVIORAL

Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.

Oral hygiene education group

Administering Oral Hygiene Education to Participants. Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.

Group Type PLACEBO_COMPARATOR

Oral hygiene education

Intervention Type BEHAVIORAL

Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard periodontal treatment protocol

Administering standard treatments for chronic periodontitis according to the current guidelines, including supragingival scaling, subgingival scaling, root planing, and periodontal flap surgery.

Intervention Type PROCEDURE

Oral hygiene education

Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 years or older.
* Aortic valve peak velocity (Vmax) between 3.0 and 3.9 m/s.
* Diagnosis of aortic valve stenosis identified as degenerative aortic valve stenosis.
* Presence of gingivitis or mild-to-moderate periodontitis confirmed by periodontal probing or panoramic dental radiography.
* Willingness to participate in the study and signing of informed consent.

Exclusion Criteria

* End-stage renal disease with eGFR \< 15 ml/min/1.73m² (according to the Cockcroft \& Gault formula).
* Pregnant, breastfeeding, and women of childbearing age (except those with effective contraception).
* Factors that may affect study follow-up or adherence to periodontal therapy.
* Patients unwilling or unable to undergo comprehensive periodontal treatment.
* Patients who do not consent to participate in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

China National Center for Cardiovascular Diseases

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Erli Zhang, MD, PhD

Role: STUDY_CHAIR

China National Center for Cardiovascular Diseases

Erli Zhang, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

China National Center for Cardiovascular Diseases

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Erli Zhang, MD, PhD

Role: CONTACT

+86-18500853301

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Erli Zhang, MD, PhD

Role: primary

86-18500853301

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-GSP-QZ-6

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TAVR With Echocardiography Guidance
NCT07035847 RECRUITING NA
Evolut PRO China Clinical Study
NCT04982588 ACTIVE_NOT_RECRUITING NA